| # | Drug | Count |
|---|---|---|
| 0 | SPIRONOLACTONE | 12 |
| 1 | VALSARTAN | 11 |
| 2 | VALSARTAN ORAL | 11 |
| 3 | RIOCIGUAT | 9 |
| 4 | SILDENAFIL | 9 |
| 5 | SILDENAFIL CITRATE | 9 |
| 6 | SILDENAFIL POWDER, | 9 |
| 7 | ASPIRIN | 6 |
| 8 | ASPIRIN 325 MG | 6 |
| 9 | ASPIRIN 81 MG | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ILOPROST | 6 | 0.0064 |
| 1 | RIOCIGUAT | 9 | 0.0003 |
| 2 | SILDENAFIL POWDER, | 9 | 0.0003 |
| 3 | TORSEMIDE | 4 | 0.0001 |
| 4 | AGALSIDASE BETA | 1 | 0.0001 |
| 5 | SPIRONOLACTONE | 12 | 0.0001 |
| 6 | OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN | 1 | 0.0001 |
| 7 | SILDENAFIL CITRATE | 9 | 0.0001 |
| 8 | METOPROLOL SUCCINATE ER TABLETS | 4 | 0.0001 |
| 9 | METOPROLOL SUCCINATE | 4 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 6 | 0.0064 |
| 1 | Soluble Guanylate Cyclase Stimulator [EPC] | 9 | 0.0003 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 11 | 0.0001 |
| 4 | Aldosterone Antagonist [EPC] | 12 | 0.0001 |
| 5 | Anticholinergic [EPC] | 1 | 0.0001 |
| 6 | Angiotensin 2 Receptor Blocker [EPC] | 11 | 0.0000 |
| 7 | Cholinergic Muscarinic Antagonist [EPC] | 1 | 0.0000 |
| 8 | Prostacycline Vasodilator [EPC] | 3 | 0.0000 |
| 9 | Endothelin Receptor Antagonist [EPC] | 4 | 0.0000 |